Comparison of alfaxalone versus propofol as anaesthetic induction agents in increasing the rate of survival and vigour of neonates
PICO question In routine canine caesareans, is alfaxalone a superior anaesthetic induction agent than propofol in increasing the rate of survival and vigour of neonates? Clinical bottom line Category of research question Treatment The number and type of study designs reviewed...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
RCVS Knowledge
2021-06-01
|
| Series: | Veterinary Evidence |
| Subjects: | |
| Online Access: | https://veterinaryevidence.org/index.php/ve/article/view/344 |
| _version_ | 1818693770823073792 |
|---|---|
| author | Lesca Monica Sofyan Fernando Martinez-Taboada |
| author_facet | Lesca Monica Sofyan Fernando Martinez-Taboada |
| author_sort | Lesca Monica Sofyan |
| collection | DOAJ |
| description | PICO question
In routine canine caesareans, is alfaxalone a superior anaesthetic induction agent than propofol in increasing the rate of survival and vigour of neonates?
Clinical bottom line
Category of research question
Treatment
The number and type of study designs reviewed
Three randomised positive clinical trials have compared the efficacy between alfaxalone and propofol in routine canine caesarean sections for increased neonatal survival and vigour
Strength of evidence
Weak
Outcomes reported
Although two studies found alfaxalone to be associated with higher Apgar scores for neonates than propofol, each study nonetheless revealed positive vigour and high survival rates from the use of either alfaxalone or propofol. The evidence is too weak to suggest that one induction agent is superior to another. The selection between the two induction agents may not be the main concern in regard to neonatal depression and 24 hour survival post-delivery, provided that the entire canine caesarean protocol is thoroughly and carefully studied
Conclusion
The evidence is too weak to suggest that alfaxolone or propofol is superior to another during canine cesareans. There is no signifcant difference seen in neonatal survival rate and vigour when using either alfaxolone or propofol
How to apply this evidence in practice
The application of evidence into practice should take into account multiple factors, not limited to: individual clinical expertise, patient’s circumstances and owners’ values, country, location or clinic where you work, the individual case in front of you, the availability of therapies and resources.
Knowledge Summaries are a resource to help reinforce or inform decision making. They do not override the responsibility or judgement of the practitioner to do what is best for the animal in their care. |
| first_indexed | 2024-12-17T13:18:58Z |
| format | Article |
| id | doaj.art-5a2af4dee8084b27bf47e93cf725e533 |
| institution | Directory Open Access Journal |
| issn | 2396-9776 |
| language | English |
| last_indexed | 2024-12-17T13:18:58Z |
| publishDate | 2021-06-01 |
| publisher | RCVS Knowledge |
| record_format | Article |
| series | Veterinary Evidence |
| spelling | doaj.art-5a2af4dee8084b27bf47e93cf725e5332022-12-21T21:46:55ZengRCVS KnowledgeVeterinary Evidence2396-97762021-06-016210.18849/ve.v6i2.344344Comparison of alfaxalone versus propofol as anaesthetic induction agents in increasing the rate of survival and vigour of neonatesLesca Monica Sofyan0Fernando Martinez-TaboadaDoctor of Veterinary Medicine StudentPICO question In routine canine caesareans, is alfaxalone a superior anaesthetic induction agent than propofol in increasing the rate of survival and vigour of neonates? Clinical bottom line Category of research question Treatment The number and type of study designs reviewed Three randomised positive clinical trials have compared the efficacy between alfaxalone and propofol in routine canine caesarean sections for increased neonatal survival and vigour Strength of evidence Weak Outcomes reported Although two studies found alfaxalone to be associated with higher Apgar scores for neonates than propofol, each study nonetheless revealed positive vigour and high survival rates from the use of either alfaxalone or propofol. The evidence is too weak to suggest that one induction agent is superior to another. The selection between the two induction agents may not be the main concern in regard to neonatal depression and 24 hour survival post-delivery, provided that the entire canine caesarean protocol is thoroughly and carefully studied Conclusion The evidence is too weak to suggest that alfaxolone or propofol is superior to another during canine cesareans. There is no signifcant difference seen in neonatal survival rate and vigour when using either alfaxolone or propofol How to apply this evidence in practice The application of evidence into practice should take into account multiple factors, not limited to: individual clinical expertise, patient’s circumstances and owners’ values, country, location or clinic where you work, the individual case in front of you, the availability of therapies and resources. Knowledge Summaries are a resource to help reinforce or inform decision making. They do not override the responsibility or judgement of the practitioner to do what is best for the animal in their care.https://veterinaryevidence.org/index.php/ve/article/view/344canineneonatealfaxalonepropofolinductionsurvivalvigourcaesarean |
| spellingShingle | Lesca Monica Sofyan Fernando Martinez-Taboada Comparison of alfaxalone versus propofol as anaesthetic induction agents in increasing the rate of survival and vigour of neonates Veterinary Evidence canine neonate alfaxalone propofol induction survival vigour caesarean |
| title | Comparison of alfaxalone versus propofol as anaesthetic induction agents in increasing the rate of survival and vigour of neonates |
| title_full | Comparison of alfaxalone versus propofol as anaesthetic induction agents in increasing the rate of survival and vigour of neonates |
| title_fullStr | Comparison of alfaxalone versus propofol as anaesthetic induction agents in increasing the rate of survival and vigour of neonates |
| title_full_unstemmed | Comparison of alfaxalone versus propofol as anaesthetic induction agents in increasing the rate of survival and vigour of neonates |
| title_short | Comparison of alfaxalone versus propofol as anaesthetic induction agents in increasing the rate of survival and vigour of neonates |
| title_sort | comparison of alfaxalone versus propofol as anaesthetic induction agents in increasing the rate of survival and vigour of neonates |
| topic | canine neonate alfaxalone propofol induction survival vigour caesarean |
| url | https://veterinaryevidence.org/index.php/ve/article/view/344 |
| work_keys_str_mv | AT lescamonicasofyan comparisonofalfaxaloneversuspropofolasanaestheticinductionagentsinincreasingtherateofsurvivalandvigourofneonates AT fernandomartineztaboada comparisonofalfaxaloneversuspropofolasanaestheticinductionagentsinincreasingtherateofsurvivalandvigourofneonates |